Facing the high—and rising—burden of antimicrobial resistance (AMR), Brazil has an opportunity to improve access, stewardship, and innovation for critical antimicrobials at the national, regional, and/or global level(s) by modifying procurement arrangements. Brazil is positioned for significant dome...
Most non-DAC cooperation providers show openness to multi-partner engagement for development, but whether and how such openness can be transformed into more active cooperation—if not deeper collaboration—for development, including between DAC and non-DAC actors, remains to be seen.
Almost 140,000 people die with a drug-resistant bacterial infection in Brazil every year due in large part to shortcomings in access, stewardship, and innovation for antimicrobials. Brazil’s existing Productive Development Partnerships system could be modified to reduce incentives for overselling an...
Antimicrobial resistance (AMR) poses a threat to global health security worldwide, and India carries one of the largest burdens of drug-resistant pathogens. The widespread misuse and overuse of antimicrobials is a major cause of the emergence and spread of resistant microorganisms. This study assess...
This paper explores how and whether responses to COVID-19, particularly from non-DAC actors, have deepened the transition from an “international” to a “global” development paradigm, and it considers implications for the future of development cooperation.
This note was first published as evidence submitted to the joint inquiry of the UK All-Party Parliamentary Groups (APPGs) on WASH and Antibiotics into the links between antibiotic resistance and lack of access to WASH.
This working paper aims to synthesise existing research and thinking on how antimicrobials are procured and ways to improve the current purchasing system.